Delivery Order V797D30107-36E79721N0050
Award Date
8/5/21
Potential Completion Date
1/31/22
Potential Value
$133K
Federal Agency
National Acquisition Center
Awardee
Mylan Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Morgantown, WV 26505, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Department of Veterans Affairs National Acquisition Center to Mylan Pharmaceuticals Inc., a for-profit manufacturer of pharmaceutical goods. The order is for the supply of the drug spironolactone as part of the VA's Pharmaceutical Prime Vendor program, which supports the healthcare needs of U.S. veterans. The fixed-price delivery order has a potential value of $110,985.84 and a completion date of January 31, 2022. Mylan has previously held prime...
This is a delivery order awarded to Mylan Pharmaceuticals Inc., a for-profit manufacturer of pharmaceutical goods, by the Department of Veterans Affairs National Acquisition Center. The order is for the supply of spironolactone, a prescription medication, in support of the VA Pharmaceutical Prime Vendor program. The delivery order has a firm fixed price of $127,360.80 and a completion date of February 28, 2021. This order is placed under Mylan's existing Federal Supply Schedule contract with the...
This is a delivery order awarded by the Department of Veterans Affairs National Acquisition Center to Mylan Pharmaceuticals Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The $81,874.80 firm fixed-price contract is for the delivery of spironolactone, a prescription medication, in support of the VA's Pharmaceutical Prime Vendor program. The order has an ultimate completion date of January 31, 2022 and does not utilize a set-aside. Mylan is a for-profit...
This is a delivery order awarded by the Department of Veterans Affairs National Acquisition Center to Mylan Pharmaceuticals Inc., a for-profit manufacturer of pharmaceutical goods. The order, valued at $220,152.24, is for the supply of the drug spironolactone in support of the VA Pharmaceutical Prime Vendor program. Spironolactone is a cardiovascular medication that will be distributed to VA medical facilities for use in veteran patient care. Mylan has previously held other prime contracts...
This federal contract award is for a bulk delivery order of spironolactone tablets placed by the Department of Veterans Affairs (VA) National Acquisition Center with Mylan Pharmaceuticals Inc. The contract has a potential value of $136,339.20 and is a Blanket Purchase Agreement (BPA) call order under Mylan's existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs. The contract will support the VA's Pharmaceutical Repackaging Program, which provides critical medications to...
This federal contract award is a delivery order for spironolactone tablets issued by the Department of Veterans Affairs National Acquisition Center to Mylan Pharmaceuticals Inc., a for-profit manufacturer of pharmaceutical goods. The order is placed under a Blanket Purchase Agreement (BPA) call, which is part of the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract vehicle. The order has a potential value of $124,977.60 and a completion date of January 31, 2018. The contract...
This is a Blanket Purchase Agreement (BPA) awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Mylan Pharmaceuticals Inc. for the supply of spironolactone tablets. The BPA is issued under the VA's Pharmaceutical Prime Vendor program and has a ceiling value of $82,371.60. It is not set aside for any specific business type. The contract is a Firm Fixed Price vehicle with an ultimate completion date of November 30, 2016. It is a call against a larger Federal Supply...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,567,478,971 units of 100mg Spironolactone tablets over a term ending on March 7, 2025. The $2,031.08 Firm Fixed Price contract was awarded on March 6, 2025 by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Spironolactone 50 mg tablets. The contract has a ceiling value of $1,208.32 and an ultimate completion date of November 8, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $5,997.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,560,731 units of Spironolactone 50 mg tablets, a cardiovascular medication. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through November 2026. This IDC serves as the...